Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NIH × FluLaval × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 110 Magnetic Resonance Spectroscopy 72 Biopsy 65 Cyclophosphamide 21 pembrolizumab 20 fludarabine 17 Cisplatin 16 Taxes 14 Nivolumab 14 Platinum 13 Paclitaxel 13 Immunoglobulin G 13 Disulfides 13 1,2-diaminocyclohexaneplatinum II citrate 13 venetoclax 12 X-Rays 11 Radiation 11 Carboplatin 11 Radiotherapy 9 Gemcitabine 9 aldesleukin 8 Doxorubicin 8 olaparib 7 durvalumab 7 atezolizumab 7 trastuzumab deruxtecan 6 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 decitabine and cedazuridine drug combination 6 Rituximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡